Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Current Deferred Revenue (2019 - 2025)

Pulmonx has reported Current Deferred Revenue over the past 7 years, most recently at $18000.0 for Q4 2025.

  • Quarterly Current Deferred Revenue fell 82.0% to $18000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18000.0 through Dec 2025, down 82.0% year-over-year, with the annual reading at $18000.0 for FY2025, 82.0% down from the prior year.
  • Current Deferred Revenue was $18000.0 for Q4 2025 at Pulmonx, down from $92000.0 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $200000.0 in Q3 2021 and troughed at $18000.0 in Q4 2025.
  • The 5-year median for Current Deferred Revenue is $100000.0 (2021), against an average of $108300.0.
  • Year-over-year, Current Deferred Revenue surged 117.39% in 2021 and then plummeted 82.0% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $200000.0 in 2021, then crashed by 50.0% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then plummeted by 82.0% to $18000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Current Deferred Revenue are $18000.0 (Q4 2025), $92000.0 (Q3 2025), and $100000.0 (Q2 2025).